Hepatocellular carcinoma: an epidemiologic view
- PMID: 12394209
- DOI: 10.1097/00004836-200211002-00002
Hepatocellular carcinoma: an epidemiologic view
Abstract
Hepatocellular carcinoma (HCC) is the fifth most common malignancy in the world and is estimated to cause approximately half a million deaths annually. Because of its high fatality rates, the incidence and mortality rates are almost equal. The major risk factors for HCC are chronic hepatitis B virus infection, chronic hepatitis C virus (HCV) infection, and alcoholic cirrhosis. The epidemiology of HCC is characterized by marked demographic (age, gender, race/ethnicity) and geographic variations. Hepatitis B virus infection, with and without aflatoxin exposure, is responsible for most cases in developing countries; better control of these risk factors has resulted in a recent decline in HCC in some places like Taiwan and China. Recently, however, a trend of rising rates of HCC has been reported from several developed countries in Europe and North America. These new trends are associated with "new" risk factors such as HCV and, possibly, diabetes. In the United States, the incidence of HCC has approximately doubled over the past 3 decades. White individuals are two to three times less often affected than African Americans, who in turn are two to three times less often affected than Asians, Pacific Islanders, or Native Americans. Men are two to three times more often affected than women. Concomitant with the rising rates of HCC, there has been a shift of incidence from typically elderly patients to relatively younger patients between ages of 40 to 60 years. An increase in HCV-related HCC accounts for at least half of the witnessed increase in HCC in the United States. Hepatocellular carcinoma continues to carry an overall dismal survival rate (close to 5%); very few patients qualify for and receive potentially curative therapy. The future incidence trends of HCC will be determined to a large extent by the clinical course of HCV-infected people.
Similar articles
-
Hepatocellular carcinoma: recent trends in the United States.Gastroenterology. 2004 Nov;127(5 Suppl 1):S27-34. doi: 10.1053/j.gastro.2004.09.013. Gastroenterology. 2004. PMID: 15508094 Review.
-
Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.J La State Med Soc. 2011 Jul-Aug;163(4):185-90. J La State Med Soc. 2011. PMID: 21954650
-
The epidemiology and prevention of hepatocellular carcinoma.Semin Oncol. 2001 Oct;28(5):441-9. doi: 10.1016/s0093-7754(01)90137-x. Semin Oncol. 2001. PMID: 11685737 Review.
-
Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease.Aliment Pharmacol Ther. 2017 Dec;46(11-12):1061-1069. doi: 10.1111/apt.14342. Epub 2017 Sep 28. Aliment Pharmacol Ther. 2017. PMID: 28960360
-
Global trends and predictions in hepatocellular carcinoma mortality.J Hepatol. 2017 Aug;67(2):302-309. doi: 10.1016/j.jhep.2017.03.011. Epub 2017 Mar 21. J Hepatol. 2017. PMID: 28336466
Cited by
-
Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective.J Parasit Dis. 2016 Sep;40(3):976-80. doi: 10.1007/s12639-014-0618-0. Epub 2014 Dec 20. J Parasit Dis. 2016. PMID: 27605822 Free PMC article.
-
Hepatocellular carcinoma in Egypt: a single center study over a decade.World J Gastroenterol. 2005 Sep 7;11(33):5193-8. doi: 10.3748/wjg.v11.i33.5193. World J Gastroenterol. 2005. PMID: 16127751 Free PMC article.
-
The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production.Hepatology. 2009 Dec;50(6):1756-64. doi: 10.1002/hep.23232. Hepatology. 2009. PMID: 19839005 Free PMC article.
-
Definitive locoregional therapy (LRT) versus bridging LRT and liver transplantation with wait-and-not-treat approach for very early stage hepatocellular carcinoma.Diagn Interv Radiol. 2018 Jul;24(4):213-218. doi: 10.5152/dir.2018.17418. Diagn Interv Radiol. 2018. PMID: 30091712 Free PMC article.
-
Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis.PeerJ. 2019 Aug 8;7:e7436. doi: 10.7717/peerj.7436. eCollection 2019. PeerJ. 2019. PMID: 31410310 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous